Nathanael Gray - Publications

Publications (8)

XB-PERS-2332

Publications By Nathanael Gray

???pagination.result.count???

???pagination.result.page??? 1

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15., Faust TB, Yoon H, Nowak RP, Donovan KA, Li Z, Cai Q, Eleuteri NA, Zhang T, Gray NS, Fischer ES., Nat Chem Biol. January 1, 2020; 16 (1): 7-14.
Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen., Kwiatkowski N, Deng X, Wang J, Tan L, Villa F, Santaguida S, Huang HC, Mitchison T, Musacchio A, Gray N., ACS Chem Biol. January 20, 2012; 7 (1): 185-96.
Discovery of selective aminothiazole aurora kinase inhibitors., Andersen CB, Wan Y, Chang JW, Riggs B, Lee C, Liu Y, Sessa F, Villa F, Kwiatkowski N, Suzuki M, Nallan L, Heald R, Musacchio A, Gray NS., ACS Chem Biol. March 20, 2008; 3 (3): 180-92.
Identification of a novel protein regulating microtubule stability through a chemical approach., Wignall SM, Gray NS, Chang YT, Juarez L, Jacob R, Burlingame A, Schultz PG, Heald R., Chem Biol. January 1, 2004; 11 (1): 135-46.
Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors., Chang YT, Wignall SM, Rosania GR, Gray NS, Hanson SR, Su AI, Merlie J, Moon HS, Sangankar SB, Perez O, Heald R, Schultz PG., J Med Chem. December 20, 2001; 44 (26): 4497-500.
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors., Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF, Le Roch K, Doerig C, Schultz P, Meijer L., Chem Biol. June 1, 2000; 7 (6): 411-22.
A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts., Rosania GR, Merlie J, Gray N, Chang YT, Schultz PG, Heald R., Proc Natl Acad Sci U S A. April 27, 1999; 96 (9): 4797-802.
Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site., Hood WF, Gray NM, Dappen MS, Watson GB, Compton RP, Cordi AA, Lanthorn TH, Monahan JB., J Pharmacol Exp Ther. August 1, 1992; 262 (2): 654-60.

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15., Faust TB, Yoon H, Nowak RP, Donovan KA, Li Z, Cai Q, Eleuteri NA, Zhang T, Gray NS, Fischer ES., Nat Chem Biol. January 1, 2020; 16 (1): 7-14.

Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen., Kwiatkowski N, Deng X, Wang J, Tan L, Villa F, Santaguida S, Huang HC, Mitchison T, Musacchio A, Gray N., ACS Chem Biol. January 20, 2012; 7 (1): 185-96.

Discovery of selective aminothiazole aurora kinase inhibitors., Andersen CB, Wan Y, Chang JW, Riggs B, Lee C, Liu Y, Sessa F, Villa F, Kwiatkowski N, Suzuki M, Nallan L, Heald R, Musacchio A, Gray NS., ACS Chem Biol. March 20, 2008; 3 (3): 180-92.

Identification of a novel protein regulating microtubule stability through a chemical approach., Wignall SM, Gray NS, Chang YT, Juarez L, Jacob R, Burlingame A, Schultz PG, Heald R., Chem Biol. January 1, 2004; 11 (1): 135-46.

Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors., Chang YT, Wignall SM, Rosania GR, Gray NS, Hanson SR, Su AI, Merlie J, Moon HS, Sangankar SB, Perez O, Heald R, Schultz PG., J Med Chem. December 20, 2001; 44 (26): 4497-500.

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors., Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF, Le Roch K, Doerig C, Schultz P, Meijer L., Chem Biol. June 1, 2000; 7 (6): 411-22.

A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts., Rosania GR, Merlie J, Gray N, Chang YT, Schultz PG, Heald R., Proc Natl Acad Sci U S A. April 27, 1999; 96 (9): 4797-802.

Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site., Hood WF, Gray NM, Dappen MS, Watson GB, Compton RP, Cordi AA, Lanthorn TH, Monahan JB., J Pharmacol Exp Ther. August 1, 1992; 262 (2): 654-60.

???pagination.result.page??? 1